OtherGastrointestinal, Hepatic, Pulmonary, and Renal
In-vitro and in-vivo pharmacological characterisation of indacaterol (5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one), a novel inhaled β2 adrenoceptor agonist with a 24-hour duration of action
Cliff Battram, Steven J. Charlton, Bernard Cuenoud, Mark R. Dowling, Robin A. Fairhurst, David Farr, John R. Fozard, Juliet R. Leighton-Davies, Christine A. Lewis, Lorraine McEvoy, Robert J. Turner and Alexandre Trifilieff
Journal of Pharmacology and Experimental Therapeutics January 24, 2006, DOI: https://doi.org/10.1124/jpet.105.098251
Cliff Battram
Steven J. Charlton
Bernard Cuenoud
Mark R. Dowling
Robin A. Fairhurst
David Farr
John R. Fozard
Juliet R. Leighton-Davies
Christine A. Lewis
Lorraine McEvoy
Robert J. Turner
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherGastrointestinal, Hepatic, Pulmonary, and Renal
In-vitro and in-vivo pharmacological characterisation of indacaterol (5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one), a novel inhaled β2 adrenoceptor agonist with a 24-hour duration of action
Cliff Battram, Steven J. Charlton, Bernard Cuenoud, Mark R. Dowling, Robin A. Fairhurst, David Farr, John R. Fozard, Juliet R. Leighton-Davies, Christine A. Lewis, Lorraine McEvoy, Robert J. Turner and Alexandre Trifilieff
Journal of Pharmacology and Experimental Therapeutics January 24, 2006, DOI: https://doi.org/10.1124/jpet.105.098251
OtherGastrointestinal, Hepatic, Pulmonary, and Renal
In-vitro and in-vivo pharmacological characterisation of indacaterol (5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one), a novel inhaled β2 adrenoceptor agonist with a 24-hour duration of action
Cliff Battram, Steven J. Charlton, Bernard Cuenoud, Mark R. Dowling, Robin A. Fairhurst, David Farr, John R. Fozard, Juliet R. Leighton-Davies, Christine A. Lewis, Lorraine McEvoy, Robert J. Turner and Alexandre Trifilieff
Journal of Pharmacology and Experimental Therapeutics January 24, 2006, DOI: https://doi.org/10.1124/jpet.105.098251
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement